depression glp 1 Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine Targeting the GLP-1 receptor pathways

Youll earn points on this purchase automatically when logged in.

Zimmermann T, Thomas L, Baader-Pagler T, Haebel P, Simon E, Reindl W, et al

Discontinue use if skin becomes irritated

Consulte um profissional de saude antes do uso.

The glucagon component can also cause transient increases in heart rate and blood glucose, effects that do not occur with amylin-based compounds

Therefore, treatment approaches in these patients depend on various clinical factors, including presence of the symptoms, possibility of significant structural disease progression, disease localization, disease volume or burden, and location of the metastatic lesion [1,4,6]